Nature-inspired nanomaterials and nanobiotechnologies for medical diagnostics (biosensing/bioimaging), drug and genome screening, targeted nanotherapeutics, antimicrobials, theranostic nanomedicine, and translational MedTech innovation.
• Nanomedicine and Nanobiotechnology: Development of multifunctional nano-therapeutics, including bio-nanomaterials for photothermal (PTT)/photodynamic (PDT) therapies and nanoformulations for targeted drug and gene delivery.
• Smart Nano-Biosensors and Bioimaging Probes: Engineering intelligent biosensing nanoplatforms, including AI-enabled system, and multifunctional nanoprobes for optical and MRI imaging, point-of-care diagnostics, and real-time monitoring of disease and live cells.
• Bio-inspired and Biomedical Materials: Design of bio-hybrid nanomaterials inspired by nature for enhanced therapeutic efficacy and ultrasensitive detection, including bioinspired antimicrobial nanodots, nano-biosensors for rapid pathogen detection, and theranostic nanomaterials for personalized medicine.
• Healthcare Technologies and MedTech Innovation: Translation of nanobiotechnologies into medical devices (e.g., wearable sensors), functional biomaterials (e.g., antimicrobial coatings), advanced diagnostic platforms (e.g., lab-on-a-chip), and digital health systems for precision medicine.
• High-Throughput Screening Platforms for Genomic and Drug Discovery: Development of custom assays and screening platforms for genomic DNA, protein biomarkers, small molecules, and peptide- or nucleic acid–based therapeutics to accelerate translational discovery and drug development.
• Biofunctionalization and Bio-labelling for Translational Nanomedicine: Nanoscale surface engineering and biomolecular tagging—including plasmonic, fluorescent, radiolabelled, and bio-affinity (e.g., DNA-DNA, antibody–antigen) motifs—to achieve high-specificity targeting, multimodal imaging, multiplex biosensing, and clinically relevant detection systems.